APO Research
Talk to an analyst

APO RESEARCH · REPORT

Receptor Tyrosine Protein Kinase ERBB 4

Compare research editions
View pricing & licenses

Selected research

Industry Research

Receptor Tyrosine Protein Kinase ERBB 4 Industry Research Report 2026

19 December 2025124 pages

Choose your research edition.

Industry ResearchReceptor Tyrosine Protein Kinase ERBB 4 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Receptor Tyrosine Protein Kinase ERBB 4 Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Receptor Tyrosine Protein Kinase ERBB 4 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Receptor Tyrosine Protein Kinase ERBB 4 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Receptor Tyrosine Protein Kinase ERBB 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Receptor Tyrosine Protein Kinase ERBB 4 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Receptor Tyrosine Protein Kinase ERBB 4 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Receptor Tyrosine Protein Kinase ERBB 4 include Shanghai Fosun Pharmaceutical (Group) Co Ltd, XuanZhu Pharma Co Ltd, Jiangsu Kanion Pharmaceutical Co Ltd, Pfizer Inc, Hanmi Pharmaceuticals Co Ltd, Zensun (Shanghai) Sci & Tech Co Ltd, Puma Biotechnology Inc, Minerva Neurosciences Inc and GamaMabs Pharma SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Receptor Tyrosine Protein Kinase ERBB 4 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Receptor Tyrosine Protein Kinase ERBB 4 Market by Company

Shanghai Fosun Pharmaceutical (Group) Co Ltd

XuanZhu Pharma Co Ltd

Jiangsu Kanion Pharmaceutical Co Ltd

Pfizer Inc

Hanmi Pharmaceuticals Co Ltd

Zensun (Shanghai) Sci & Tech Co Ltd

Puma Biotechnology Inc

Minerva Neurosciences Inc

GamaMabs Pharma SA

Boehringer Ingelheim GmbH

Aslan Pharmaceuticals Pte Ltd

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Type

MIN-301

NRG-4

NT-113

PB-357

Others

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Application

Systolic Heart Failure

Neuroblastoma

Oligodendroglioma

Skin Cancer

Others

Receptor Tyrosine Protein Kinase ERBB 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Receptor Tyrosine Protein Kinase ERBB 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Receptor Tyrosine Protein Kinase ERBB 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Receptor Tyrosine Protein Kinase ERBB 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Receptor Tyrosine Protein Kinase ERBB 4 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Receptor Tyrosine Protein Kinase ERBB 4 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Receptor Tyrosine Protein Kinase ERBB 4 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Receptor Tyrosine Protein Kinase ERBB 4 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue of Manufacturers (2021-2026) Table 9. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Receptor Tyrosine Protein Kinase ERBB 4 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Receptor Tyrosine Protein Kinase ERBB 4 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Product Type & Application Table 14. Global Receptor Tyrosine Protein Kinase ERBB 4 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Receptor Tyrosine Protein Kinase ERBB 4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information Table 19. Shanghai Fosun Pharmaceutical (Group) Co Ltd Business Overview Table 20. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 22. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments Table 23. XuanZhu Pharma Co Ltd Company Information Table 24. XuanZhu Pharma Co Ltd Business Overview Table 25. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 27. XuanZhu Pharma Co Ltd Recent Developments Table 28. Jiangsu Kanion Pharmaceutical Co Ltd Company Information Table 29. Jiangsu Kanion Pharmaceutical Co Ltd Business Overview Table 30. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 32. Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments Table 33. Pfizer Inc Company Information Table 34. Pfizer Inc Business Overview Table 35. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 37. Pfizer Inc Recent Developments Table 38. Hanmi Pharmaceuticals Co Ltd Company Information Table 39. Hanmi Pharmaceuticals Co Ltd Business Overview Table 40. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 42. Hanmi Pharmaceuticals Co Ltd Recent Developments Table 43. Zensun (Shanghai) Sci & Tech Co Ltd Company Information Table 44. Zensun (Shanghai) Sci & Tech Co Ltd Business Overview Table 45. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 47. Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments Table 48. Puma Biotechnology Inc Company Information Table 49. Puma Biotechnology Inc Business Overview Table 50. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 52. Puma Biotechnology Inc Recent Developments Table 53. Minerva Neurosciences Inc Company Information Table 54. Minerva Neurosciences Inc Business Overview Table 55. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 57. Minerva Neurosciences Inc Recent Developments Table 58. GamaMabs Pharma SA Company Information Table 59. GamaMabs Pharma SA Business Overview Table 60. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 62. GamaMabs Pharma SA Recent Developments Table 63. Boehringer Ingelheim GmbH Company Information Table 64. Boehringer Ingelheim GmbH Business Overview Table 65. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 67. Boehringer Ingelheim GmbH Recent Developments Table 68. Aslan Pharmaceuticals Pte Ltd Company Information Table 69. Aslan Pharmaceuticals Pte Ltd Business Overview Table 70. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio Table 72. Aslan Pharmaceuticals Pte Ltd Recent Developments Table 73. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2021-2026) & (K Units) Table 75. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2021-2026) Table 76. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region (2027-2032) & (K Units) Table 77. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Region (2027-2032) Table 78. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2021-2026) Table 80. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Region (2027-2032) Table 82. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 84. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 85. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 89. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 90. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 99. South America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 100. South America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2026) & (K Units) Table 108. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2027-2032) & (K Units) Table 109. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2026) Table 110. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2027-2032) Table 111. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2026) Table 114. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2027-2032) Table 115. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2026) & (US$/Unit) Table 116. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2027-2032) & (US$/Unit) Table 117. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2026) & (K Units) Table 118. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2027-2032) & (K Units) Table 119. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2026) Table 120. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2027-2032) Table 121. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2026) Table 124. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2027-2032) Table 125. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2026) & (US$/Unit) Table 126. Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Receptor Tyrosine Protein Kinase ERBB 4 Distributors List Table 130. Receptor Tyrosine Protein Kinase ERBB 4 Customers List Table 131. Receptor Tyrosine Protein Kinase ERBB 4 Industry Trends Table 132. Receptor Tyrosine Protein Kinase ERBB 4 Industry Drivers Table 133. Receptor Tyrosine Protein Kinase ERBB 4 Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Receptor Tyrosine Protein Kinase ERBB 4 Product Image Figure 5. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size (2021-2032) & (US$ Million) Figure 7. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (2021-2032) & (K Units) Figure 8. Global Receptor Tyrosine Protein Kinase ERBB 4 Average Price (US$/Unit) & (2021-2032) Figure 9. MIN-301 Product Image Figure 10. NRG-4 Product Image Figure 11. NT-113 Product Image Figure 12. PB-357 Product Image Figure 13. Others Product Image Figure 14. Systolic Heart Failure Product Image Figure 15. Neuroblastoma Product Image Figure 16. Oligodendroglioma Product Image Figure 17. Skin Cancer Product Image Figure 18. Others Product Image Figure 19. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Receptor Tyrosine Protein Kinase ERBB 4 Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region in 2025 Figure 25. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region in 2025 Figure 26. North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country in 2025 Figure 27. North America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2021-2032) Figure 28. North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2021-2032) Figure 29. United States Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country in 2025 Figure 32. Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2021-2032) Figure 33. Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2021-2032) Figure 34. Germany Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country in 2025 Figure 40. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2021-2032) Figure 42. China Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country in 2025 Figure 51. South America Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2021-2032) Figure 52. South America Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2021-2032) Figure 53. Mexico Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country in 2025 Figure 57. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Country (2021-2032) Figure 59. Turkey Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Receptor Tyrosine Protein Kinase ERBB 4 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2032) Figure 63. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2032) Figure 64. Global Receptor Tyrosine Protein Kinase ERBB 4 Price (US$/Unit) by Type (2021-2032) Figure 65. Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2032) Figure 66. Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2032) Figure 67. Global Receptor Tyrosine Protein Kinase ERBB 4 Price (US$/Unit) by Application (2021-2032) Figure 68. Receptor Tyrosine Protein Kinase ERBB 4 Value Chain Figure 69. Receptor Tyrosine Protein Kinase ERBB 4 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Receptor Tyrosine Protein Kinase ERBB 4 Industry Opportunities and Challenges

Scope & coverage.

Types
  • MIN-301
  • NRG-4
  • NT-113
  • PB-357
  • Others
Applications
  • Systolic Heart Failure
  • Neuroblastoma
  • Oligodendroglioma
  • Skin Cancer
  • Others
Companies covered
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • XuanZhu Pharma Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Pfizer Inc
  • Hanmi Pharmaceuticals Co Ltd
  • Zensun (Shanghai) Sci & Tech Co Ltd
  • Puma Biotechnology Inc
  • Minerva Neurosciences Inc
  • GamaMabs Pharma SA
  • Boehringer Ingelheim GmbH
  • Aslan Pharmaceuticals Pte Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size (2021-2032)
  4. 2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (2021-2032)
  5. 2.2.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Average Price (2021-2032)
  6. 2.3 Receptor Tyrosine Protein Kinase ERBB 4 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 MIN-301
  9. 2.3.3 NRG-4
  10. 2.3.4 NT-113
  11. 2.3.5 PB-357
  12. 2.3.6 Others
  13. 2.4 Receptor Tyrosine Protein Kinase ERBB 4 by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Systolic Heart Failure
  16. 2.4.3 Neuroblastoma
  17. 2.4.4 Oligodendroglioma
  18. 2.4.5 Skin Cancer
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Receptor Tyrosine Protein Kinase ERBB 4 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Receptor Tyrosine Protein Kinase ERBB 4 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Product Type & Application
  8. 3.8 Global Manufacturers of Receptor Tyrosine Protein Kinase ERBB 4, Established Date
  9. 3.9 Global Receptor Tyrosine Protein Kinase ERBB 4 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd
  2. 4.1.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information
  3. 4.1.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Business Overview
  4. 4.1.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  6. 4.1.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Developments
  7. 4.2 XuanZhu Pharma Co Ltd
  8. 4.2.1 XuanZhu Pharma Co Ltd Company Information
  9. 4.2.2 XuanZhu Pharma Co Ltd Business Overview
  10. 4.2.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  12. 4.2.5 XuanZhu Pharma Co Ltd Recent Developments
  13. 4.3 Jiangsu Kanion Pharmaceutical Co Ltd
  14. 4.3.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Information
  15. 4.3.2 Jiangsu Kanion Pharmaceutical Co Ltd Business Overview
  16. 4.3.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  18. 4.3.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Developments
  19. 4.4 Pfizer Inc
  20. 4.4.1 Pfizer Inc Company Information
  21. 4.4.2 Pfizer Inc Business Overview
  22. 4.4.3 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  24. 4.4.5 Pfizer Inc Recent Developments
  25. 4.5 Hanmi Pharmaceuticals Co Ltd
  26. 4.5.1 Hanmi Pharmaceuticals Co Ltd Company Information
  27. 4.5.2 Hanmi Pharmaceuticals Co Ltd Business Overview
  28. 4.5.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  30. 4.5.5 Hanmi Pharmaceuticals Co Ltd Recent Developments
  31. 4.6 Zensun (Shanghai) Sci & Tech Co Ltd
  32. 4.6.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Information
  33. 4.6.2 Zensun (Shanghai) Sci & Tech Co Ltd Business Overview
  34. 4.6.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  36. 4.6.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Developments
  37. 4.7 Puma Biotechnology Inc
  38. 4.7.1 Puma Biotechnology Inc Company Information
  39. 4.7.2 Puma Biotechnology Inc Business Overview
  40. 4.7.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  42. 4.7.5 Puma Biotechnology Inc Recent Developments
  43. 4.8 Minerva Neurosciences Inc
  44. 4.8.1 Minerva Neurosciences Inc Company Information
  45. 4.8.2 Minerva Neurosciences Inc Business Overview
  46. 4.8.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  48. 4.8.5 Minerva Neurosciences Inc Recent Developments
  49. 4.9 GamaMabs Pharma SA
  50. 4.9.1 GamaMabs Pharma SA Company Information
  51. 4.9.2 GamaMabs Pharma SA Business Overview
  52. 4.9.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  54. 4.9.5 GamaMabs Pharma SA Recent Developments
  55. 4.10 Boehringer Ingelheim GmbH
  56. 4.10.1 Boehringer Ingelheim GmbH Company Information
  57. 4.10.2 Boehringer Ingelheim GmbH Business Overview
  58. 4.10.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  60. 4.10.5 Boehringer Ingelheim GmbH Recent Developments
  61. 4.11 Aslan Pharmaceuticals Pte Ltd
  62. 4.11.1 Aslan Pharmaceuticals Pte Ltd Company Information
  63. 4.11.2 Aslan Pharmaceuticals Pte Ltd Business Overview
  64. 4.11.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase ERBB 4 Product Portfolio
  66. 4.11.5 Aslan Pharmaceuticals Pte Ltd Recent Developments
5 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Scenario by Region
  1. 5.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region: 2021-2032
  3. 5.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region: 2021-2026
  4. 5.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Region: 2027-2032
  5. 5.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region: 2021-2032
  6. 5.3.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region: 2021-2026
  7. 5.3.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Region: 2027-2032
  8. 5.4 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
  9. 5.4.1 North America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2032)
  11. 5.4.3 North America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
  15. 5.5.1 Europe Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2032)
  17. 5.5.3 Europe Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
  35. 5.7.1 South America Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2032)
  37. 5.7.3 South America Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032)
  2. 6.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Type (2021-2032)
  5. 6.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032)
  2. 7.1.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue by Application (2021-2032)
  5. 7.2.1 Global Receptor Tyrosine Protein Kinase ERBB 4 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Receptor Tyrosine Protein Kinase ERBB 4 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Receptor Tyrosine Protein Kinase ERBB 4 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Receptor Tyrosine Protein Kinase ERBB 4 Value Chain Analysis
  2. 8.1.1 Receptor Tyrosine Protein Kinase ERBB 4 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Receptor Tyrosine Protein Kinase ERBB 4 Production Mode & Process
  5. 8.2 Receptor Tyrosine Protein Kinase ERBB 4 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Receptor Tyrosine Protein Kinase ERBB 4 Distributors
  8. 8.2.3 Receptor Tyrosine Protein Kinase ERBB 4 Customers
9 Global Receptor Tyrosine Protein Kinase ERBB 4 Analyzing Market Dynamics
  1. 9.1 Receptor Tyrosine Protein Kinase ERBB 4 Industry Trends
  2. 9.2 Receptor Tyrosine Protein Kinase ERBB 4 Industry Drivers
  3. 9.3 Receptor Tyrosine Protein Kinase ERBB 4 Industry Opportunities and Challenges
  4. 9.4 Receptor Tyrosine Protein Kinase ERBB 4 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst